Follow the HYPERA S/A stock price and the full directors' dealings record of the company, a listed equity based in Brazil. Shares are quoted on BR BR, under the supervision of CVM (Brazil). Operating in the Health Care sector, HYPERA S/A has recorded 792 reports. Market capitalisation: €14.8bn. The latest transaction was filed on 10 June 2026 (Compra à vista (Crédito)). Among the most active insiders: Anonymous (Diretor ou Vinculado). All data is openly available.
792
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HYPERA S/A Buy (bullish), based on 14 analysts. Average price target: R$29.71.
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,227 of 26,211 companies
69.2
score / 100
Value
75
Quality
64
FCF yld12%
Earn yld8.3%
EV/EBITDA10.5x
ROE13%
Gross mgn59%
Net mgn16%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.